8-K Announcements
6Mar 11, 2026·SEC
Feb 2, 2026·SEC
Feb 2, 2026·SEC
Petco Health and Wellness Company, Inc. (WOOF) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Petco Health and Wellness Company, Inc. (WOOF) stock price & volume — 10-year historical chart
Petco Health and Wellness Company, Inc. (WOOF) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Petco Health and Wellness Company, Inc. (WOOF) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 11, 2026 | $0.01vs $0.02-50.0% | $1.5Bvs $1.5B+0.2% |
| Q4 2025 | Nov 25, 2025 | $0.05vs $0.02+204.5% | $1.5Bvs $1.5B-0.3% |
| Q3 2025 | Aug 28, 2025 | $0.08vs $0.01+700.0% | $1.5Bvs $1.5B+1.3% |
| Q3 2025 | Jun 5, 2025 | $0.01vs $0.02+50.0% | $1.5Bvs $1.5B+0.1% |
Petco Health and Wellness Company, Inc. (WOOF) competitors in Pet Products and Services Retail — business model, growth, and fundamentals comparison
Petco Health and Wellness Company, Inc. (WOOF) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Petco Health and Wellness Company, Inc. (WOOF) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Feb'19 | Feb'20 | Jan'21 | Jan'22 | Jan'23 | Feb'24 | Feb'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 4.39B | 4.43B | 4.92B | 5.81B | 6.04B | 6.26B | 6.12B | 5.96B |
| Revenue Growth % | - | 0.96% | 10.95% | 18.03% | 3.94% | 3.63% | -2.22% | -2.53% |
| Cost of Goods Sold | 2.49B | 2.53B | 2.81B | 3.38B | 3.61B | 3.9B | 3.79B | 3.66B |
| COGS % of Revenue | 56.63% | 57.01% | 57.18% | 58.21% | 59.79% | 62.37% | 62% | 61.33% |
| Gross Profit | 1.9B▲ 0% | 1.91B▲ 0.1% | 2.11B▲ 10.5% | 2.43B▲ 15.2% | 2.43B▲ 0.0% | 2.35B▼ 3.0% | 2.32B▼ 1.3% | 2.31B▼ 0.8% |
| Gross Margin % | 43.37% | 42.99% | 42.82% | 41.79% | 40.21% | 37.63% | 38% | 38.67% |
| Gross Profit Growth % | - | 0.09% | 10.5% | 15.18% | 0.02% | -3.02% | -1.25% | -0.83% |
| Operating Expenses | 1.75B | 1.8B | 1.91B | 2.16B | 2.2B | 3.53B | 2.32B | 2.18B |
| OpEx % of Revenue | 39.76% | 40.5% | 38.87% | 37.2% | 36.47% | 56.5% | 37.89% | 36.65% |
| Selling, General & Admin | 1.73B | 1.78B | 1.91B | 2.16B | 2.2B | 2.31B | 2.32B | 2.18B |
| SG&A % of Revenue | 39.32% | 40.07% | 38.87% | 37.2% | 36.47% | 36.95% | 37.89% | 36.65% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 373.17M | 19M | 0 | 0 | 0 | 1.22B | 0 | 0 |
| Operating Income | -214.72M▲ 0% | 110.6M▲ 151.5% | 194.42M▲ 75.8% | 266.07M▲ 36.9% | 225.56M▼ 15.2% | -1.18B▼ 623.3% | 7.05M▲ 100.6% | 120.43M▲ 1608.0% |
| Operating Margin % | -4.89% | 2.49% | 3.95% | 4.58% | 3.74% | -18.87% | 0.12% | 2.02% |
| Operating Income Growth % | - | 151.51% | 75.79% | 36.85% | -15.23% | -623.28% | 100.6% | 1608.03% |
| EBITDA | -27.72M | 284.14M | 369.26M | 438.5M | 419.39M | -979.53M | -1.46M | 317.14M |
| EBITDA Margin % | -0.63% | 6.41% | 7.51% | 7.55% | 6.95% | -15.66% | -0.02% | 5.32% |
| EBITDA Growth % | - | 1124.94% | 29.96% | 18.75% | -4.36% | -333.56% | 99.85% | 21777.58% |
| D&A (Non-Cash Add-back) | 187M | 173.54M | 174.84M | 172.43M | 193.83M | 200.78M | -8.51M | 196.71M |
| EBIT | -214.76M | 110.94M | 177.53M | 279.79M | 213.92M | -1.17B | 15.56M | 120.43M |
| Net Interest Income | -243.32M | -252.68M | -218.43M | -77.33M | -100.61M | -147.5M | -139.82M | -124.89M |
| Interest Income | 420K | 335K | 653K | 62K | 1.03M | 3.4M | 3.71M | 6.3M |
| Interest Expense | 243.74M | 253.02M | 219.08M | 77.4M | 101.64M | 150.91M | 143.53M | 131.2M |
| Other Income/Expense | -243.78M | -250.24M | -235.98M | -52.79M | -100.3M | -127.51M | -116.35M | -105.1M |
| Pretax Income | -458.5M▲ 0% | -139.64M▲ 69.5% | -41.55M▲ 70.2% | 213.28M▲ 613.2% | 125.26M▼ 41.3% | -1.31B▼ 1144.1% | -109.3M▲ 91.6% | 15.33M▲ 114.0% |
| Pretax Margin % | -10.44% | -3.15% | -0.84% | 3.67% | 2.08% | -20.91% | -1.79% | 0.26% |
| Income Tax | -45.84M | -35.66M | -3.34M | 53.47M | 35.35M | -27.61M | -7.48M | 6.27M |
| Effective Tax Rate % | 10% | 25.54% | 8.03% | 25.07% | 28.22% | 2.11% | 6.84% | 40.87% |
| Net Income | -413.79M▲ 0% | -95.87M▲ 76.8% | -26.48M▲ 72.4% | 164.42M▲ 720.8% | 90.8M▼ 44.8% | -1.28B▼ 1509.9% | -101.82M▲ 92.0% | 9.07M▲ 108.9% |
| Net Margin % | -9.42% | -2.16% | -0.54% | 2.83% | 1.5% | -20.47% | -1.66% | 0.15% |
| Net Income Growth % | - | 76.83% | 72.38% | 720.84% | -44.77% | -1509.91% | 92.05% | 108.9% |
| Net Income (Continuing) | -413.79M | -103.98M | -38.22M | 159.81M | 89.91M | -1.28B | -101.82M | 9.07M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | -8.33M | -13.58M | -18.2M | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.28▲ 0% | -0.07▲ 76.5% | -0.13▼ 97.9% | 0.62▲ 576.9% | 0.34▼ 45.2% | -4.78▼ 1505.9% | -0.37▲ 92.3% | 0.03▲ 108.6% |
| EPS Growth % | - | 76.54% | -97.87% | 576.92% | -45.16% | -1505.88% | 92.26% | 108.57% |
| EPS (Basic) | -0.28 | -0.07 | -0.13 | 0.62 | 0.34 | -4.78 | -0.37 | 0.03 |
| Diluted Shares Outstanding | 1.46B | 1.46B | 210.68M | 265.34M | 265.95M | 267.55M | 273.41M | 286.15M |
| Basic Shares Outstanding | 1.46B | 1.44B | 203.72M | 265.19M | 265.52M | 267.55M | 273.41M | 279.56M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
Petco Health and Wellness Company, Inc. (WOOF) balance sheet — assets, liabilities & shareholders' equity
| Line item | Feb'19 | Feb'20 | Jan'21 | Jan'22 | Jan'23 | Feb'24 | Feb'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 761.61M | 711M | 777.55M | 1.07B | 1.02B | 951.74M | 973.62M | 1.02B |
| Cash & Short-Term Investments | 180.65M | 148.78M | 111.4M | 211.6M | 201.9M | 125.43M | 165.76M | 256.74M |
| Cash Only | 180.65M | 148.78M | 111.4M | 211.6M | 201.9M | 125.43M | 165.76M | 256.74M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 27.88M | 31.52M | 41.83M | 55.62M | 49.58M | 44.37M | 40.42M | 45.81M |
| Days Sales Outstanding | 2.32 | 2.59 | 3.1 | 3.5 | 3 | 2.59 | 2.41 | 2.8 |
| Inventory | 470.14M | 478.97M | 538.67M | 675.11M | 652.43M | 684.5M | 653.33M | 590.21M |
| Days Inventory Outstanding | 68.99 | 69.15 | 69.88 | 72.89 | 65.99 | 64.04 | 62.89 | 58.92 |
| Other Current Assets | 34.17M | 26.88M | 45.61M | 86.09M | 60.81M | 38.83M | 60.59M | 127.03M |
| Total Non-Current Assets | 4.16B | 5.45B | 5.3B | 5.43B | 5.6B | 4.41B | 4.22B | 4.15B |
| Property, Plant & Equipment | 683.55M | 2.12B | 1.96B | 2.07B | 2.2B | 2.2B | 2.03B | 1.94B |
| Fixed Asset Turnover | 6.43x | 2.10x | 2.52x | 2.81x | 2.74x | 2.84x | 3.02x | 3.07x |
| Goodwill | 2.18B | 2.18B | 2.18B | 2.18B | 2.19B | 980.3M | 980.06M | 980.06M |
| Intangible Assets | 1.17B | 1.03B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 13.95M | 0 |
| Other Non-Current Assets | 130.93M | 122.39M | 138.19M | 152.79M | 176.81M | 205.69M | 174.02M | 1.23B |
| Total Assets | 4.92B▲ 0% | 6.16B▲ 25.0% | 6.08B▼ 1.3% | 6.5B▲ 6.9% | 6.61B▲ 1.8% | 5.36B▼ 18.9% | 5.19B▼ 3.1% | 5.17B▼ 0.4% |
| Asset Turnover | 0.89x | 0.72x | 0.81x | 0.89x | 0.91x | 1.17x | 1.18x | 1.15x |
| Asset Growth % | - | 24.99% | -1.29% | 6.95% | 1.77% | -18.9% | -3.15% | -0.4% |
| Total Current Liabilities | 543.47M | 841.94M | 875.31M | 1.05B | 1.02B | 1.11B | 1.14B | 1.13B |
| Accounts Payable | 276.93M | 293.2M | 339.49M | 403.98M | 381.21M | 485.13M | 492.88M | 450.55M |
| Days Payables Outstanding | 40.64 | 42.33 | 44.04 | 43.62 | 38.56 | 45.39 | 47.44 | 44.98 |
| Short-Term Debt | 28.35M | 28.64M | 2.2M | 21.76M | 22.79M | 15.96M | 23.31M | 324.69M |
| Deferred Revenue (Current) | 0 | 0 | 15.53M | 18M | 23.05M | 33.52M | 29.56M | 0 |
| Other Current Liabilities | 94.27M | 93.69M | 129.48M | 150.63M | 89.93M | 85.3M | 134.15M | 358.9M |
| Current Ratio | 1.40x | 0.84x | 0.89x | 1.02x | 0.99x | 0.86x | 0.85x | 0.90x |
| Quick Ratio | 0.54x | 0.28x | 0.27x | 0.38x | 0.36x | 0.24x | 0.28x | 0.38x |
| Cash Conversion Cycle | 30.67 | 29.42 | 28.94 | 32.77 | 30.43 | 21.24 | 17.86 | 16.75 |
| Total Non-Current Liabilities | 3.74B | 4.75B | 3.15B | 3.19B | 3.21B | 3.07B | 2.94B | 2.88B |
| Long-Term Debt | 3.2B | 3.23B | 1.65B | 1.64B | 1.63B | 1.58B | 1.58B | 1.05B |
| Capital Lease Obligations | 0 | 1.16B | 1.1B | 1.12B | 1.17B | 1.12B | 1.05B | 1.05B |
| Deferred Tax Liabilities | 304.2M | 265.28M | 280.92M | 318.36M | 303.12M | 251.63M | 217.71M | 234.91M |
| Other Non-Current Liabilities | 241.38M | 101.65M | 122.92M | 109.05M | 106.84M | 112.9M | 100.18M | 104.41M |
| Total Liabilities | 4.29B | 5.59B | 4.02B | 4.24B | 4.23B | 4.18B | 4.08B | 4.01B |
| Total Debt | 3.23B | 4.69B | 3B | 3.05B | 3.13B | 3.04B | 2.96B | 1.37B |
| Net Debt | 3.05B | 4.54B | 2.89B | 2.84B | 2.93B | 2.92B | 2.79B | 1.12B |
| Debt / Equity | 5.06x | 8.36x | 1.46x | 1.35x | 1.32x | 2.57x | 2.66x | 1.18x |
| Debt / EBITDA | - | 16.51x | 8.13x | 6.95x | 7.47x | - | - | 4.33x |
| Net Debt / EBITDA | - | 15.99x | 7.83x | 6.47x | 6.99x | - | - | 3.52x |
| Interest Coverage | -0.88x | 0.44x | 0.89x | 3.44x | 2.22x | -7.82x | 0.05x | 0.92x |
| Total Equity | 637.91M▲ 0% | 561.06M▼ 12.0% | 2.06B▲ 266.3% | 2.26B▲ 9.8% | 2.38B▲ 5.6% | 1.18B▼ 50.3% | 1.11B▼ 6.0% | 1.16B▲ 4.5% |
| Equity Growth % | - | -12.05% | 266.32% | 9.76% | 5.57% | -50.26% | -5.98% | 4.55% |
| Book Value per Share | 0.44 | 0.38 | 9.76 | 8.50 | 8.95 | 4.43 | 4.07 | 4.07 |
| Total Shareholders' Equity | 637.91M | 569.39M | 2.07B | 2.27B | 2.38B | 1.18B | 1.11B | 1.16B |
| Common Stock | 1.35B | 1.36B | 264K | 265K | 266K | 269K | 277K | 282K |
| Retained Earnings | -707.52M | -780.47M | -22.25M | 142.17M | 232.97M | -1.05B | -1.15B | -1.14B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.19M | -8.27M | -1.27M | -2.24M | -4.1M | 1.82M | -18.08M | -8.39M |
| Minority Interest | 0 | -8.33M | -13.58M | -18.2M | 0 | 0 | 0 | 0 |
Petco Health and Wellness Company, Inc. (WOOF) cash flow — operating, investing & free cash flow history
| Line item | Feb'19 | Feb'20 | Jan'21 | Jan'22 | Jan'23 | Feb'24 | Feb'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 203.2M | 110.34M | 268.62M | 358.21M | 346M | 215.72M | 177.67M | 314.05M |
| Operating CF Margin % | 4.63% | 2.49% | 5.46% | 6.17% | 5.73% | 3.45% | 2.9% | 5.27% |
| Operating CF Growth % | - | -45.7% | 143.45% | 33.36% | -3.41% | -37.65% | -17.64% | 76.76% |
| Net Income | -413.79M | -103.98M | -31.74M | 159.81M | 89.91M | -1.28B | -101.82M | 9.07M |
| Depreciation & Amortization | 187M | 173.54M | 174.84M | 172.43M | 193.83M | 200.78M | 199.73M | 196.71M |
| Stock-Based Compensation | 8.45M | 9.49M | 12.91M | 49.27M | 60.78M | 81.86M | 50.21M | 32.65M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.05M |
| Other Non-Cash Items | 364.91M | 452.47M | 517.21M | 452.38M | 428.69M | 1.59B | 370.98M | 396.49M |
| Working Capital Changes | 56.63M | -421.18M | -404.61M | -475.66M | -427.21M | -372.06M | -341.43M | -337.91M |
| Change in Receivables | 23.63M | -3.85M | -10.31M | -13.79M | 6.04M | 5.21M | 4.18M | -5.62M |
| Change in Inventory | 644K | -8.19M | -60.63M | -136.4M | 22.68M | -32.07M | 30.77M | 63.12M |
| Change in Payables | 23.77M | 15.93M | 46.3M | 71.78M | -22.76M | 103.92M | 8.48M | -42.99M |
| Cash from Investing | -142.68M | -139.04M | -157.19M | -237.08M | -320.32M | -207.44M | -123.9M | -124.56M |
| Capital Expenditures | -148.06M | -156.91M | -159.56M | -239.11M | -278.02M | -225.6M | -127.99M | -127.1M |
| CapEx % of Revenue | 3.37% | 3.54% | 3.24% | 4.12% | 4.61% | 3.61% | 2.09% | 2.13% |
| Acquisitions | 0 | -1.61M | 0 | -4.33M | -44.64M | -6.72M | -629K | 2.54M |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 6.15M | 20.06M | 3.3M | 226K | 2.34M | 0 | 4.17M | 0 |
| Cash from Financing | -32.1M | -3.07M | -146.61M | -18.78M | -33.84M | -85.35M | -8.75M | -101.75M |
| Debt Issued (Net) | -28.14M | 303K | -1.08B | 5.58M | -22.08M | -80.92M | -5.71M | -95.25M |
| Equity Issued (Net) | -111K | 0 | 1000K | 0 | 0 | 0 | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -111K | 0 | -105K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -3.85M | -3.37M | -250K | -24.36M | -11.76M | -4.43M | -5.55M | -10.17M |
| Net Change in Cash | 28.42M▲ 0% | -31.77M▼ 211.8% | -35.18M▼ 10.7% | 102.35M▲ 390.9% | -8.16M▼ 108.0% | -77.08M▼ 844.2% | 45.02M▲ 158.4% | 87.75M▲ 94.9% |
| Free Cash Flow | 54.84M▲ 0% | -47.02M▼ 185.7% | 109.06M▲ 331.9% | 119.11M▲ 9.2% | 67.98M▼ 42.9% | -9.88M▼ 114.5% | 49.68M▲ 602.9% | 314.05M▲ 532.1% |
| FCF Margin % | 1.25% | -1.06% | 2.22% | 2.05% | 1.13% | -0.16% | 0.81% | 5.27% |
| FCF Growth % | - | -185.74% | 331.94% | 9.22% | -42.92% | -114.53% | 602.92% | 532.11% |
| FCF per Share | 0.04 | -0.03 | 0.52 | 0.45 | 0.26 | -0.04 | 0.18 | 1.10 |
| FCF Conversion (FCF/Net Income) | -0.49x | -1.15x | -10.14x | 2.18x | 3.81x | -0.17x | -1.75x | 34.64x |
| Interest Paid | 213.25M | 217.66M | 178.96M | 64.55M | 89.28M | 142.11M | 138.62M | 0 |
| Taxes Paid | 11.38M | 15.04M | 2.39M | 16.09M | 14.44M | 32.19M | 34.84M | 0 |
Petco Health and Wellness Company, Inc. (WOOF) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -64.87% | -15.99% | -2.02% | 7.63% | 3.92% | -71.8% | -8.86% | 0.8% |
| Return on Invested Capital (ROIC) | -4.37% | 1.89% | 2.9% | 3.98% | 3.25% | -18.81% | 0.13% | 2.92% |
| Gross Margin | 43.37% | 42.99% | 42.82% | 41.79% | 40.21% | 37.63% | 38% | 38.67% |
| Net Margin | -9.42% | -2.16% | -0.54% | 2.83% | 1.5% | -20.47% | -1.66% | 0.15% |
| Debt / Equity | 5.06x | 8.36x | 1.46x | 1.35x | 1.32x | 2.57x | 2.66x | 1.18x |
| Interest Coverage | -0.88x | 0.44x | 0.89x | 3.44x | 2.22x | -7.82x | 0.05x | 0.92x |
| FCF Conversion | -0.49x | -1.15x | -10.14x | 2.18x | 3.81x | -0.17x | -1.75x | 34.64x |
| Revenue Growth | - | 0.96% | 10.95% | 18.03% | 3.94% | 3.63% | -2.22% | -2.53% |
Petco Health and Wellness Company, Inc. (WOOF) SEC filings — annual & quarterly reports (10-K, 10-Q)
Mar 11, 2026·SEC
Feb 2, 2026·SEC
Feb 2, 2026·SEC
Petco Health and Wellness Company, Inc. (WOOF) stock FAQ — growth, dividends, profitability & financials explained
Petco Health and Wellness Company, Inc. (WOOF) reported $5.96B in revenue for fiscal year 2025. This represents a 36% increase from $4.39B in 2018.
Petco Health and Wellness Company, Inc. (WOOF) saw revenue decline by 2.5% over the past year.
Yes, Petco Health and Wellness Company, Inc. (WOOF) is profitable, generating $9.1M in net income for fiscal year 2025 (0.2% net margin).
Petco Health and Wellness Company, Inc. (WOOF) has a return on equity (ROE) of 0.8%. This is below average, suggesting room for improvement.
Petco Health and Wellness Company, Inc. (WOOF) generated $285.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Petco Health and Wellness Company, Inc. (WOOF) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates